Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dutch Ophthalmic Research Center
Zuidland, South Holland, Netherlandsdorcglobal.com ↗
- Ownership
- Private
- Employees
- ~800
- Development stage
- Commercial
01
Overview
DORC has over four decades of experience as a global leader in innovative ophthalmic surgical equipment, exporting to more than eighty countries with direct sales in fifteen markets. The company’s solutions are widely adopted by surgeons worldwide and have contributed significantly to advances in vitreoretinal and combined eye surgeries. In April 2024, it was acquired by Carl Zeiss Meditec AG to further expand its reach and innovation pipeline.
- Therapeutic areas
- Ophthalmology
- Modalities
- Device
- Industry
- Surgical Medical Devices
02
Partnerships
No specific major pharma/biotech partnerships disclosed; close collaborations with leading eye surgeons globally for R&D/product development.
Beyond the preview
Go deeper on Dutch Ophthalmic Research Center.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dutch Ophthalmic Research Center.